|Bid||84.68 x 800|
|Ask||84.69 x 900|
|Day's Range||84.09 - 84.96|
|52 Week Range||77.04 - 98.52|
|Beta (5Y Monthly)||0.55|
|PE Ratio (TTM)||21.43|
|Forward Dividend & Yield||3.20 (3.85%)|
|Ex-Dividend Date||Mar 04, 2021|
|1y Target Est||104.80|
Subscribe to Yahoo Finance Plus to view Fair Value for NVSLearn more
Invisible Nation is a worldwide network of patient organizations committed to driving a decline in cardiovascular (CV) death by effecting systemic change in atherosclerotic cardiovascular disease (ASCVD) care Facilitated by Novartis, Invisible Nation will aim to reduce and ultimately prevent many of the 15 million1 ASCVD deaths each year and dramatically lower what is estimated to become $1 trillion in annual CV disease care cost by 20302Network members will engage policymakers, healthcare syste
These stocks are all trading near their 52-week lows, but they're all solid investments to hold over the long term.
Jonathan Moore, one of the first employees of Vertex Pharmaceuticals Inc. and a key scientist behind the company's renowned cystic fibrosis drugs, has a new venture called Rectify Pharmaceuticals.